Page 41 - Lipids News Today

Bunge Loders Croklaan – a global producer and supplier of plant-based lipids – is bringing its novel NuliGo molecule to the US market to support muscle health in the trending sports nutrition and active aging categories.

Some patients with side-effect concerns aiming to lessen their statin burden may prefer the treat-to-target approach, if they respond well to lesser-intensity statins, say researchers.

Risk factors for statin intolerance include female sex, obesity, hypothyroidism, diabetes, antiarrhythmics, alcohol use, exercise, chronic liver disease, and chronic kidney failure, studies suggest.

The researchers are calling for more sex-specific research to guide clinical practice.

A new oral formulation of a PCSK9-inhibitor, cholesterol-lowering drug has shown encouraging results in a phase 2 study.

Cardiology clinics receiving educational and advisory guidance improved their treatment of patients with type 2 diabetes and atherosclerotic disease.

The Philippine government should set aside more resources for health as the country’s current spending is still low compared to regional peers and in order to improve labor productivity, according to a study of the Philippine Institute for Development Studies.

A new study shows how urate-lowering therapy (ULT) is related to such conditions as chronic kidney disease (CKD) and cardiovascular disease (CVD).

But one lipid expert has highlighted limitations of the observational study and advised caution in interpreting the results.

Plant-based vegetarian and vegan diets may have the lowest carbon footprint among diets eaten in the US, but fish-based pescatarian diets are the healthiest, suggests a new data analysis.